OCULAR THERAPEUTIX, INC — Director's Dealing 2021

Feb 19, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OCULAR THERAPEUTIX, INC (OCUL)
CIK: 0001393434
Period of Report: 2021-02-17

Reporting Person: Notman Donald (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-02-17	Stock Option (Right to Buy)	$18.31	A	190000	Acquired	2031-02-16	Common Stock (190000)	Direct

Footnotes

F1: Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant.